Beeken BioMedical Overview
- Founded
-
2010
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$8.83M
Beeken BioMedical General Information
Description
Developer of hemostasis wound dressing products developed for the advancement of bleeding control. The company's products offer hemostasis wound dressing and polymer-based liquid bandage products that help reduce blood flow after an injury and protect wounds from infections, enabling first responders, and hospital patient care providers to rapidly control bleeding by using the products to establish hemostasis and stability to patients.
Contact Information
Website
www.beekenbiomedical.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Medical Supplies
Primary Office
- 378 Page Street
- Suite 201
- Stoughton, MA 02072
- United States
+1 (888) 000-0000
Beeken BioMedical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Seed Round | 18-Aug-2020 | $8.83M | 00.000 | Completed | Generating Revenue |
Beeken BioMedical Patents
Beeken BioMedical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3148597-A4 | Hemostatic textile | Inactive | 28-May-2014 | 000000000 | 0 |
| EP-3148597-A2 | Hemostatic textile | Inactive | 28-May-2014 | 000000000 | |
| US-10406255-B2 | Hemostatic textile | Active | 28-May-2014 | 000000000 | 00 |
| US-20150343111-A1 | Hemostatic textile | Active | 28-May-2014 | 000000000 | |
| CA-2917291-A1 | Knit hemostatic bandage with glass fiber | Pending | 19-Oct-2012 | A61F13/00012 |
Beeken BioMedical Executive Team (3)
Beeken BioMedical Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| Charles Blixt JD | Self | Board Member | 000 0000 |
| Peter Beemsterboer | Beeken BioMedical | Co-Founder, President & Chairman | 000 0000 |
| Richard Kendall | Beeken BioMedical | Co-Founder, President, Chief Executive Officer & Board Member | 000 0000 |
Beeken BioMedical Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
